J Gen Virol Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Gen Virol 70 (1989), 2637-2644; DOI 10.1099/0022-1317-70-10-2637
© 1989 Society for General Microbiology

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brideau, R. J.
Right arrow Articles by Wathen, M. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brideau, R. J.
Right arrow Articles by Wathen, M. W.
Agricola
Right arrow Articles by Brideau, R. J.
Right arrow Articles by Wathen, M. W.

Protection of Cotton Rats against Human Respiratory Syncytial Virus by Vaccination with a Novel Chimeric FG Glycoprotein

R. J. Brideau, R. R. Walters, M. A. Stier and M. W. Wathen

The Upjohn Company, 301 Henrietta Street, Kalamazoo, Michigan 49001, U.S.A.

The cotton rat model of experimental human respiratory syncytial virus (RSV) infection was used to study the efficacy of FG, a novel chimeric glycoprotein which was expressed in insect cells using a baculovirus vector. FG contained the extracellular regions of the F (fusion) and G (attachment) glycoproteins of RSV. Vaccination with FG resulted in induction of neutralizing antibody and was correlated with protection of lung tissue from RSV challenge against both serogroup A and B virus strains. Both crude FG taken from supernatants of insect cells and affinity-purified FG were immunogenic and active against RSV. FG vaccination was effective by three routes of administration, following a single dose, and when administered with different adjuvants.

Keywords: RSV, human, glycoprotein protection

Received 8 March 1989; accepted 8 June 1989.


This article has been cited by other articles:


Home page
J. Virol.Home page
G. A. Prince, C. Capiau, M. Deschamps, L. Fabry, N. Garçon, D. Gheysen, J.-P. Prieels, G. Thiry, O. Van Opstal, and D. D. Porter
Efficacy and Safety Studies of a Recombinant Chimeric Respiratory Syncytial Virus FG Glycoprotein Vaccine in Cotton Rats
J. Virol., November 15, 2000; 74(22): 10287 - 10292.
[Abstract] [Full Text]


Home page
Clin. Microbiol. Rev.Home page
W. M. Sullender
Respiratory Syncytial Virus Genetic and Antigenic Diversity
Clin. Microbiol. Rev., January 1, 2000; 13(1): 1 - 15.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 1989 by the Society for General Microbiology.